<?xml version="1.0" encoding="UTF-8"?>
<p id="para0003">In vitro, chloroquine appears as a versatile bioactive agent reported to possess antiviral activity against RNA viruses as diverse as rabies virus 
 <xref rid="bib0016" ref-type="bibr">[16]</xref>, poliovirus 
 <xref rid="bib0017" ref-type="bibr">[17]</xref>, HIV 
 <xref rid="bib0012" ref-type="bibr">[12</xref>,
 <xref rid="bib0018" ref-type="bibr">[18]</xref>, 
 <xref rid="bib0019" ref-type="bibr">[19]</xref>, 
 <xref rid="bib0020" ref-type="bibr">[20]</xref>, hepatitis A virus 
 <xref rid="bib0021" ref-type="bibr">[21</xref>,
 <xref rid="bib0022" ref-type="bibr">22]</xref>, hepatitis C virus 
 <xref rid="bib0023" ref-type="bibr">[23]</xref>, influenza A and B viruses 
 <xref rid="bib0024" ref-type="bibr">[24]</xref>, 
 <xref rid="bib0025" ref-type="bibr">[25]</xref>, 
 <xref rid="bib0026" ref-type="bibr">[26]</xref>, 
 <xref rid="bib0027" ref-type="bibr">[27]</xref>, influenza A H5N1 virus 
 <xref rid="bib0028" ref-type="bibr">[28]</xref>, Chikungunya virus 
 <xref rid="bib0029" ref-type="bibr">[29]</xref>, 
 <xref rid="bib0030" ref-type="bibr">[30]</xref>, 
 <xref rid="bib0031" ref-type="bibr">[31]</xref>, Dengue virus 
 <xref rid="bib0032" ref-type="bibr">[32</xref>,
 <xref rid="bib0033" ref-type="bibr">33]</xref>, Zika virus 
 <xref rid="bib0034" ref-type="bibr">[34]</xref>, Lassa virus 
 <xref rid="bib0035" ref-type="bibr">[35]</xref>, Hendra and Nipah viruses 
 <xref rid="bib0036" ref-type="bibr">[36</xref>,
 <xref rid="bib0037" ref-type="bibr">37]</xref>, Crimeanâ€“Congo hemorrhagic fever virus 
 <xref rid="bib0038" ref-type="bibr">[38]</xref> and Ebola virus 
 <xref rid="bib0039" ref-type="bibr">[39]</xref>, as well as various DNA viruses such as hepatitis B virus 
 <xref rid="bib0040" ref-type="bibr">[40]</xref> and herpes simplex virus 
 <xref rid="bib0041" ref-type="bibr">[41]</xref>.The antiviral properties of chloroquine described in vitro have sometimes been confirmed during treatment of virus-infected patients but have not always been reproduced in clinical trials depending on the disease, the concentration of chloroquine used, the duration of treatment and the clinical team in charge of the trial.
</p>
